North America accounted largest revenue share 59.31% in 2024
With its ability to promote sustainable weight loss, semaglutide has gained immense popularity with its commercial alternatives, such as Wegovy and Ozempic
BPC-157 Tissue Repair Studies Published preclinical studies on BPC-157 have examined tendon-to-bone healing, intestinal anastomosis recovery, and musculoskeletal injury models in rodents
The company constantly improve the product structure, "to create Shimu brand, carving enterprise elite" as business goals, to ensure that products meet the market requirement, the company is using the major agricultural and animal husbandry institutions, research institutes as the basis
This makes ISHFERTIN M a strong contender in the nutraceutical segment